Taipei, Taiwan

Chen-Wei Jao

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Patent Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chen-Wei Jao. Retrieved from https://idiyas.com/inventor/chen-wei-jao-sxt1hs7f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chen-Wei Jao: Innovator in Liquid Crystalline Compounds

Introduction

Chen-Wei Jao is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of liquid crystalline compounds. With a focus on innovation, he has secured a patent that showcases his expertise and creativity.

Latest Patents

Chen-Wei Jao holds a patent for liquid crystalline compounds. This invention reflects his dedication to advancing technology in this specialized area. His work has the potential to impact various applications in the industry.

Career Highlights

Currently, Chen-Wei Jao is employed at Merck Patent GmbH. His role at the company allows him to further develop his ideas and contribute to groundbreaking research. His career is marked by a commitment to innovation and excellence.

Collaborations

Chen-Wei collaborates with Marc Sauer, a fellow innovator in the field. Their partnership exemplifies the spirit of teamwork in advancing scientific research and development.

Conclusion

Chen-Wei Jao is a notable inventor whose work in liquid crystalline compounds has made a significant impact. His contributions to the field and collaboration with other professionals highlight the importance of innovation in technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…